颞骨双层探测器双能CT用于识别胆脂瘤
本研究回顾性纳入871例耳区软组织密度影患者中的87例疑似颞骨胆脂瘤患者,评估双层探测器双能CT解剖与定量参数的诊断效能,并建立评分系统。Zeff ≤7.12伴盾板破坏的评分系统AUC达0.868,显著优于各单项参数,可作为识别胆脂瘤的影像标志物。
要点
- Zeff ≤7.12伴盾板破坏的评分系统AUC为0.868,显著优于各单项参数。
- Zeff单项诊断AUC最高(0.786),其次为能谱曲线斜率(0.784)。
- 该评分系统可能有助于胆脂瘤的早期识别。
核心结论
- 基于双层探测器双能CT的评分系统(Zeff ≤7.12伴盾板破坏)可作为识别胆脂瘤的创新影像标志物,AUC达0.868,显著优于各单项参数(均p < 0.05)。
研究设计与样本
- 回顾性研究,2023年8月至2024年7月在本机构纳入871例耳区软组织密度影行DL-DECT检查的患者,最终87例疑似颞骨胆脂瘤患者纳入分析(中位年龄51岁,男45例、女42例),以手术病理为参考标准分为胆脂瘤组44例和非胆脂瘤组43例。
关键影像表现/征象
- 胆脂瘤组与非胆脂瘤组依据手术病理结果划分,影像评估包括解剖参数(盾板破坏)和定量参数(Zeff、能谱曲线斜率、CT40 keV)。
- 盾板破坏单项诊断AUC为0.759。
诊断标准与关键数值
- Zeff诊断胆脂瘤的AUC为0.786。
- 能谱曲线斜率诊断胆脂瘤的AUC为0.784。
- 盾板破坏诊断胆脂瘤的AUC为0.759。
- CT40 keV诊断胆脂瘤的AUC为0.724。
- 评分系统达到2分(Zeff ≤7.12伴盾板破坏)时,ROC分析AUC为0.868(95%CI:0.778-0.931),显著优于各单项参数(均p < 0.05)。
临床应用与阅片要点
- 对于耳区软组织密度影患者,可关注Zeff值及盾板是否破坏,两者组合的评分系统有助于识别胆脂瘤。
- 评分系统达到2分(Zeff ≤7.12伴盾板破坏)时提示胆脂瘤可能,该评分系统可能有助于早期识别胆脂瘤。
局限性
- 本研究为回顾性研究。
- 原文结论指出该评分系统可能有助于胆脂瘤的早期识别,并可能通过及时干预改善患者结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Cholesteatomas (CSs) are locally aggressive and can infiltrate adjacent structures as they expand. This study aimed to establish a straightforward scoring system using dual-layer detector dual-energy CT (DL-DECT) to improve the identification of cholesteatomas in patients.
MATERIALS AND METHODS: Between August 2023 and July 2024, 871 patients with soft tissue density shadows in the ear region who underwent DL-DECT examination were retrospectively enrolled at our institute. Surgical treatments followed by pathological examinations were performed. Based on pathological findings, the lesions were classified into cholesteatoma (CS) and non-cholesteatoma (non-CS) groups. The diagnostic performance of anatomical and quantitative parameters derived from DL-DECT was evaluated using receiver operating characteristic (ROC) curve analysis. Logistic regression was applied to develop a diagnostic scoring system.
RESULTS: A total of 87 patients (median age, 51 years; 45 men and 42 women) with suspected temporal bone CS were included, comprising 44 CS cases and 43 non-CS cases. The effective atomic number (Zeff) demonstrated the highest diagnostic accuracy (area under the curve [AUC] = 0.786), followed by the slope of the energy spectral curve (AUC = 0.784), scutum destruction (AUC = 0.759), and CT40 keV (AUC = 0.724). Logistic regression identified two significant predictors, which were incorporated into the scoring system. When the system score reached 2 points (Zeff ≤ 7.12 accompanied by scutum destruction), the AUC in the ROC analysis reached 0.868 (95% confidence interval: 0.778-0.931), significantly outperforming each individual parameter (all p < 0.05).
CONCLUSION: The DL-DECT-derived scoring system serves as an innovative imaging marker for detecting CSs.
KEY POINTS: Question Accurate differentiation between CSs and non-CSs is critical for selecting surgical approaches. However, high-resolution CT demonstrates limited discriminatory power. Findings A straightforward diagnostic scoring system incorporating Zeff ≤ 7.12 and scutum destruction was developed to efficiently identify patients with CS. Clinical relevance This scoring system may facilitate the early identification of CS, potentially improving patient outcomes through timely intervention.
引用
- Fan X, Ding C, Gao S, et al. Temporal bone dual-layer detector dual-energy computed tomography for identifying cholesteatoma. Eur Radiol. 2025. PMID: 40782221. doi:10.1007/s00330-025-11813-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。